Story

Aurubis Stock Slides as U.S. Plant Delay Overshadows Strong Earnings

ENTHMSVIIDZHZH-TWJAKOHI
Aug 7, 20262 min read
Aurubis Stock Slides as U.S. Plant Delay Overshadows Strong Earnings
Text size
Background

Shares in German copper producer Aurubis AG (NAFG) fell nearly 5% in recent trading, extending losses from the previous session. The decline came as investors reacted to news of a significant delay in the company's U.S. expansion, a development that overshadowed a quarterly earnings report that strongly surpassed analyst expectations.

U.S. Expansion Hits Snag

The primary driver for the stock's decline is a revised timeline for the ramp-up of Aurubis's new recycling facility in Richmond, Virginia. The company disclosed that the project has been pushed back by approximately six months for each phase.

  • Phase 1 completion is now anticipated in the fiscal year 2026/27.
  • Phase 2 completion has been moved to the fiscal year 2027/28.

This delay in a key strategic growth project has become a structural concern for investors, outweighing the company's strong current performance and impacting its medium-term operating targets.

Strong Earnings Go Unrewarded

The announcement of the delay was made alongside otherwise impressive financial results for the third quarter of fiscal year 2026. The company's core business demonstrated robust health, but this positive news was largely ignored by the market.

Sample IUX Markets – In-articleAd
  • Operating pre-tax profit surged approximately 160% year-over-year to €149 million, well above the analyst consensus of €128 million.
  • Quarterly revenue jumped 40% to €6.45 billion.

Despite the strong operational performance, the market has prioritized the revised timeline for the company's U.S. growth ambitions, leading to sustained selling pressure.

Analyst and Market Reaction

Analysts have offered a mixed but cautious response. UBS maintained its Neutral rating, with analyst Daniel Major citing the Richmond delay as the "key negative from the quarter." Deutsche Bank reiterated a Hold rating while slightly trimming its price target. In contrast, Warburg Research kept its Buy rating but acknowledged the extended U.S. timeline was a disappointment.

The stock's decline was also amplified by profit-taking after a significant rally from its 52-week low. A subdued broader market, with Germany's DAX 40 trading near flatline, provided little support for European industrial stocks.

Read next

More on Stocks
Back to latest news

LATEST